Showing results (41-50 of 390) with videos related to

Sort By:
Pageof 39
Nature Medicine|August 1, 2017
Implications of human genetic variation in CRISPR-based therapeutic genome editingDavid A Scott, Feng Zhang
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 23, 2022
Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?: Insights and Perspectives From the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) AddendumAntonia Morga, Nicholas R Latimer, Martin Scott, et al.
Journal of Comparative Effectiveness Research|June 9, 2022
Adjusting for treatment crossover in the MAVORIC trial: survival in advanced mycosis fungoides and Sézary syndromeNeil Hawkins, Noemi Muszbek, Rachel Evans, et al.
Pharmacoeconomics|November 8, 2017
Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology AssessmentJaclyn Beca, Don Husereau, Kelvin K W Chan, et al.
European Heart Journal|November 30, 2010
Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction)Cecilia Linde, Stuart Mealing, Neil Hawkins, et al.
The Cochrane Database of Systematic Reviews|April 15, 2016
Management strategies for pancreatic pseudocystsKurinchi Selvan Gurusamy, Elena Pallari, Neil Hawkins, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2016
Using [U-13C6]-Glucose Tracer to Study Metabolic Changes in Oncogene-Induced Senescence FibroblastsKaterina I Leonova, David A Scott
British Journal of Anaesthesia|September 24, 2025
Using perioperative patient safety guidelines to drive systems changeJennifer M Weller, David A Scott
Anesthesia and Analgesia|May 9, 2020
Informed Consent in Patients With Frailty SyndromeBrendan S Silbert, David A Scott
Cardiovascular Therapeutics|September 9, 2021
Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-AnalysisRupert Bauersachs, Olivia Wu, Neil Hawkins, et al.
Pageof 39